Cargando…
ALK阳性非小细胞肺癌患者克唑替尼耐药的机制和治疗措施
Lung cancer is the common lethal disease with the highest morbidity and mortality worldwide. Non-small cell lung cancer (NSCLC) is the most common histological type of lung cancer. Recently, the advances in the molecular biology have transformed our view of NSCLC from histopathological descriptions...
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
中国肺癌杂志编辑部
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5999845/ https://www.ncbi.nlm.nih.gov/pubmed/25676398 http://dx.doi.org/10.3779/j.issn.1009-3419.2015.02.03 |
Ejemplares similares
-
ALK阳性非小细胞肺癌的诊断
Publicado: (2015) -
初露端倪——演绎ALK阳性非小细胞肺癌的中国故事
Publicado: (2015) -
增强免疫组化和原位杂交方法检测非小细胞肺癌的ALK重排的临床可行性
Publicado: (2015) -
Crizotinib治疗ALK阳性伴骨髓转移的肺腺癌1例及文献复习
Publicado: (2015) -
EML4-ALK融合基因阳性肺腺癌合并淋巴瘤1例并文献复习
Publicado: (2015)